社区获得性肺炎病原学及耐药现状研究进展

Etiology and antibiotic resistance of community-acquired pneumonia

社区获得性肺炎(CAP)是亚洲成人病死的主要原因之一。近年来,尽管诊断技术在不断进步,新型抗菌药物陆续上市,但CAP的发病率和病死率仍然较高。不同研究中CAP病原菌分布各有不同,耐药情况也有所差异。本文对社区获得性肺炎的病原学及耐药现状进行综述,为临床治疗提供参考。

Community-acquired pneumonia（CAP） is a major cause of adult mortality in Asia. In recent years, despite the continuous advancement in diagnostic technology and the successive listing of new antibiotics, the incidence and mortality of CAP are still relatively high. In different studies, the distribution of pathogenic bacteria in CAP and the drug resistance varies. This article reviews the etiology and drug resistance of community-acquired pneumonia, and provides reference for clinical treatment.